We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026

Automated, Compact, Random Access Chemistry Analyzer Featured at AACC

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: An automated, compact, random access chemistry analyzer is a cost-effective system designed for clinical chemistry and specialty testing.

Called Indiko, the Thermo Scientific (Waltham, MA, USA) chemical analyzer is being showcased at the 2012 annual conference of the American Association for Clinical Chemistry (AACC) Expo held at the Los Angeles Convention Center from July 15-19, 2012.

The benchtop analyzer is designed for routine clinical chemistry testing in small laboratory settings and specialty testing such as specific proteins, drug of abuse testing, and therapeutic drug monitoring including immunosuppressant drug monitoring (ISD).
A mix of bar-coded primary tubes and sample cups increase the flexibility of any operation. More...
Patient oriented testing produces results quickly thus improving the quality of patient care.

With a small footprint, the Indiko analyzer fits ideally in a laboratory with space limitations. The graphical design of the user interface is supported by a touch screen.

Indiko includes several automated features, such as advanced dilution management and real-time monitoring of reagent usage, which help to manage a daily workload fluently. Samples, reagents, and consumables can continuously be loaded without interrupting the testing process, and different sample types can be analyzed at the same time.

A real-time QC program with multiple Westgard Rules assures the reliable performance. Application data as well as calibrator and control values are loadable from a file or from a two-dimensional barcode by the barcode scanner. The test flow definition allows for up to four reagent additions in each test, offering automation even for the most complex methods. The special cuvette design supports low reagent volumes thus reducing operating costs, especially important when working with specialty tests. Each cuvette is used only once to ensure accurate and precise results.

Related Links:
Thermofisher Scientific



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The circulating tumor DNA blood test could provide earlier warning of post-transplant recurrence (Photo courtesy of Shutterstock)

Blood Test Could Enable Earlier Detection of Liver Cancer Recurrence After Transplant

Liver cancer is a leading cause of cancer deaths worldwide, with more than 800,000 diagnoses and over 700,000 deaths each year. Disease recurrence after liver transplantation is common and is associated... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.